Ace investor Vijay Kedia, through Kedia Securities Private Ltd, acquired 1.38 lakh shares of Mangalam Drugs for Rs 33.27 lakh in a bulk deal. The shares were purchased at a premium of Rs 24.15 per equity share, above the Friday closing price. This investment comes as Mangalam Drugs, a microcap company known for anti-malaria APIs, has seen its stock price fall over 70% in the past year, trading significantly below its 52-week high.